Mitochondrial genome variation in male LHON patients with the m.11778G > A mutation.


Journal

Metabolic brain disease
ISSN: 1573-7365
Titre abrégé: Metab Brain Dis
Pays: United States
ID NLM: 8610370

Informations de publication

Date de publication:
12 2020
Historique:
received: 12 05 2020
accepted: 21 07 2020
pubmed: 3 8 2020
medline: 3 9 2021
entrez: 3 8 2020
Statut: ppublish

Résumé

Leber hereditary optic neuropathy (LHON) is a mitochondrial disorder with symptoms limited to a single tissue, optic nerve, resulting in vision loss. In the majority of cases it is caused by one of three point mutations in mitochondrial DNA (mtDNA) but their presence is not sufficient for disease development, since ~50% of men and ~10% women who carry them are affected. Thus additional modifying factors must exist. In this study, we use next generation sequencing to investigate the role of whole mtDNA variation in male Polish patients with LHON and m.11778G > A, the most frequent LHON mutation. We present a possible association between mtDNA haplogroup K and variants in its background, a combination of m.3480A > G, m.9055G > A, m.11299 T > C and m.14167C > T, and LHON mutation. These variants may have a negative effect on m.11778G > A increasing its penetrance and the risk of LHON in the Polish population. Surprisingly, we did not observe associations previously reported for m.11778G > A and LHON in European populations, particularly for haplogroup J as a risk factor, implying that mtDNA variation is much more complex. Our results indicate possible contribution of novel combination of mtDNA genetic factors to the LHON phenotype.

Identifiants

pubmed: 32740724
doi: 10.1007/s11011-020-00605-3
pii: 10.1007/s11011-020-00605-3
pmc: PMC7584531
doi:

Substances chimiques

DNA, Mitochondrial 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1317-1327

Références

Am J Hum Genet. 2011 Apr 8;88(4):433-9
pubmed: 21457906
Mitochondrion. 2017 Sep;36:130-137
pubmed: 28716668
Nature. 1981 Apr 9;290(5806):457-65
pubmed: 7219534
PLoS One. 2013;8(3):e58993
pubmed: 23533597
Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4598-4602
pubmed: 30242360
Prog Retin Eye Res. 2011 Mar;30(2):81-114
pubmed: 21112411
Am J Hum Genet. 2004 Feb;74(2):229-38
pubmed: 14712420
Sci Rep. 2020 Feb 17;10(1):2766
pubmed: 32066781
Nat Rev Genet. 2011 Aug 31;12(10):683-91
pubmed: 21878961
Mitochondrion. 2017 May;34:141-146
pubmed: 28396254
Am J Hum Genet. 1997 May;60(5):1107-21
pubmed: 9150158
Brain. 2014 Feb;137(Pt 2):335-53
pubmed: 24369379
Curr Protoc Bioinformatics. 2013 Dec;44:1.23.1-26
pubmed: 25489354
Am J Hum Genet. 2007 Aug;81(2):228-33
pubmed: 17668373
Asia Pac J Ophthalmol (Phila). 2018 Jul-Aug;7(4):242-245
pubmed: 30008192
Clin Ophthalmol. 2015 Jun 26;9:1165-76
pubmed: 26170609
Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3225-9
pubmed: 15713802
Curr Opin Genet Dev. 2009 Jun;19(3):212-9
pubmed: 19481926
Hum Genet. 2002 Feb;110(2):130-8
pubmed: 11935318
J Pathol. 2012 Jan;226(2):274-86
pubmed: 21989606
Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):1119-23
pubmed: 20211598
Brain. 2016 Jan;139(Pt 1):e1
pubmed: 26209315
Nat Rev Genet. 2012 Dec;13(12):878-90
pubmed: 23154810
Gene. 2015 Jan 15;555(1):41-9
pubmed: 25261848
Exp Eye Res. 2019 Jan;178:186-197
pubmed: 30312593
Genet Med. 2019 Jun;21(6):1407-1416
pubmed: 30393377
Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4211-20
pubmed: 17003408
Annu Rev Biochem. 2007;76:679-99
pubmed: 17408359
J Med Genet. 2004 Apr;41(4):e41
pubmed: 15060117
J Genet Genomics. 2017 Mar 20;44(3):139-149
pubmed: 28298255
Am J Hum Genet. 2006 Apr;78(4):564-74
pubmed: 16532388
Hum Mutat. 2009 Feb;30(2):E386-94
pubmed: 18853457
J Biol Chem. 2000 Dec 22;275(51):39831-6
pubmed: 10976107
Eur J Hum Genet. 2019 Aug;27(8):1304-1314
pubmed: 30903113
Hum Mol Genet. 2008 Dec 15;17(24):4001-11
pubmed: 18806273
PLoS Genet. 2009 May;5(5):e1000474
pubmed: 19424428
Biochem Biophys Res Commun. 2002 Jul 12;295(2):342-7
pubmed: 12150954
J Ophthalmol. 2011;2011:179412
pubmed: 21253496
BMC Cancer. 2012 Feb 02;12:53
pubmed: 22299657
Biomed Rep. 2018 Jan;8(1):51-58
pubmed: 29387390
Am J Hum Genet. 1997 Feb;60(2):381-7
pubmed: 9012411
Am J Hum Genet. 1996 Aug;59(2):481-5
pubmed: 8755941
J Med Genet. 2009 Mar;46(3):145-58
pubmed: 19001017
PLoS Genet. 2017 Dec 18;13(12):e1007126
pubmed: 29253894
Ann Neurol. 2000 Aug;48(2):188-93
pubmed: 10939569
Science. 1988 Dec 9;242(4884):1427-30
pubmed: 3201231
Hum Genet. 2006 Apr;119(3):241-54
pubmed: 16408223
Front Genet. 2019 Jan 08;9:702
pubmed: 30671084

Auteurs

Agnieszka Piotrowska-Nowak (A)

Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, 5a Pawińskiego Street, 02-106, Warsaw, Poland. apiotrowska@biol.uw.edu.pl.

Maciej R Krawczyński (MR)

Department of Medical Genetics, Poznań University of Medical Sciences, 8 Rokietnicka Street, 60-806, Poznań, Poland.
Centers for Medical Genetics GENESIS, 4 Grudzieniec Street, 60-601, Poznań, Poland.

Ewa Kosior-Jarecka (E)

Department of Diagnostics and Microsurgery of Glaucoma, Medical University of Lublin, 1 Chmielna Street, 20-079, Lublin, Poland.

Anna M Ambroziak (AM)

Faculty of Physics, University of Warsaw, 5 Pasteur Street, 02-093, Warsaw, Poland.

Magdalena Korwin (M)

Department of Ophthalmology, Medical University of Warsaw, 13 Sierakowskiego Street, 03-709, Warsaw, Poland.

Monika Ołdak (M)

Department of Genetics, Institute of Physiology and Pathology of Hearing, 10 Mochnackiego Street, 02-042, Warsaw, Poland.
Department of Histology and Embryology, Center of Biostructure Research, Medical University of Warsaw, 5 Chałubińskiego Street, 02-004, Warsaw, Poland.

Katarzyna Tońska (K)

Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, 5a Pawińskiego Street, 02-106, Warsaw, Poland.

Ewa Bartnik (E)

Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, 5a Pawińskiego Street, 02-106, Warsaw, Poland.
Institute of Biochemistry and Biophysics Polish Academy of Sciences, 5a Pawińskiego Street, 02-106, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH